Hardman Johnston Global Advisors LLC Astrazeneca PLC Transaction History

Hardman Johnston Global Advisors LLC

$2.46 Billion
Q3 2024

A detailed history of Hardman Johnston Global Advisors LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Hardman Johnston Global Advisors LLC holds 558,488 shares of AZN stock, worth $36.3 Million. This represents 1.77% of its overall portfolio holdings.

Number of Shares

558,488

Previous 568,289 1.72%

Holding current value

$36.3 Million

Previous $44.3 Million 1.81%

% of portfolio

1.77%

Previous 1.78%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 30, 2024	SELL	$76.67 - $87.62 $751,442 - $858,763	-9,801 Reduced 1.72%	558,488 $43.5 Million
Q2 2024 Aug 14, 2024	SELL	$66.81 - $80.83 $1.13 Million - $1.37 Million	-16,958 Reduced 2.9%	568,289 $44.3 Million
Q1 2024 May 06, 2024	SELL	$61.03 - $69.57 $2.42 Million - $2.76 Million	-39,724 Reduced 6.36%	585,247 $39.7 Million
Q4 2023 Jan 29, 2024	SELL	$61.89 - $69.28 $1.77 Million - $1.99 Million	-28,656 Reduced 4.38%	624,971 $42.1 Million
Q3 2023 Oct 20, 2023	SELL	$64.85 - $71.7 $1.1 Million - $1.22 Million	-16,988 Reduced 2.53%	653,627 $44.3 Million
Q2 2023 Aug 11, 2023	SELL	$69.91 - $75.81 $988,946 - $1.07 Million	-14,146 Reduced 2.07%	670,615 $48 Million
Q1 2023 May 05, 2023	SELL	$63.15 - $71.6 $687,387 - $779,365	-10,885 Reduced 1.56%	684,761 $47.5 Million
Q4 2022 Feb 03, 2023	SELL	$54.21 - $70.44 $4.68 Million - $6.08 Million	-86,330 Reduced 11.04%	695,646 $47.2 Million
Q3 2022 Nov 02, 2022	SELL	$53.02 - $135.75 $605,753 - $1.55 Million	-11,425 Reduced 1.44%	781,976 $42.9 Million
Q2 2022 Aug 02, 2022	SELL	$59.26 - $71.14 $14.7 Million - $17.7 Million	-248,488 Reduced 23.85%	793,401 $52.4 Million
Q1 2022 May 12, 2022	SELL	$55.72 - $67.12 $1.07 Million - $1.29 Million	-19,220 Reduced 1.81%	1,041,889 $69.1 Million
Q4 2021 Jan 26, 2022	SELL	$54.02 - $63.83 $3.45 Million - $4.07 Million	-63,781 Reduced 5.67%	1,061,109 $61.8 Million
Q3 2021 Nov 12, 2021	BUY	$55.56 - $60.79 $420,033 - $459,572	7,560 Added 0.68%	1,124,890 $67.6 Million
Q2 2021 Aug 09, 2021	BUY	$48.42 - $60.18 $16.4 Million - $20.4 Million	339,663 Added 43.68%	1,117,330 $66.9 Million
Q1 2021 May 12, 2021	SELL	$47.16 - $54.44 $7.84 Million - $9.05 Million	-166,210 Reduced 17.61%	777,667 $38.7 Million
Q4 2020 Feb 11, 2021	SELL	$48.52 - $58.02 $2,426 - $2,901	-50 Reduced 0.01%	943,877 $47.2 Million
Q3 2020 Nov 16, 2020	BUY	$53.07 - $61.1 $1.79 Million - $2.06 Million	33,635 Added 3.69%	943,927 $51.7 Million
Q2 2020 Jul 23, 2020	SELL	$43.1 - $55.31 $6.85 Million - $8.79 Million	-158,836 Reduced 14.86%	910,292 $48.1 Million
Q1 2020 May 04, 2020	SELL	$37.79 - $51.33 $1.97 Million - $2.68 Million	-52,190 Reduced 4.65%	1,069,128 $47.7 Million
Q4 2019 Feb 05, 2020	SELL	$42.46 - $50.46 $44,583 - $52,983	-1,050 Reduced 0.09%	1,121,318 $55.9 Million
Q3 2019 Oct 30, 2019	BUY	$40.12 - $45.47 $60,982 - $69,114	1,520 Added 0.14%	1,122,368 $50 Million
Q2 2019 Aug 05, 2019	SELL	$37.28 - $41.68 $418,654 - $468,066	-11,230 Reduced 0.99%	1,120,848 $46.3 Million
Q1 2019 May 03, 2019	BUY	$35.49 - $43.02 $241,793 - $293,095	6,813 Added 0.61%	1,132,078 $45.8 Million
Q4 2018 Feb 06, 2019	SELL	$36.86 - $41.49 $7.81 Million - $8.8 Million	-212,014 Reduced 15.85%	1,125,265 $42.7 Million
Q3 2018 Oct 18, 2018	BUY	$34.76 - $39.72 $3.7 Million - $4.22 Million	106,320 Added 8.64%	1,337,279 $52.9 Million
Q2 2018 Jul 18, 2018	SELL	$34.55 - $37.05 $411,939 - $441,747	-11,923 Reduced 0.96%	1,230,959 $43.2 Million
Q1 2018 Apr 30, 2018	BUY	$32.97 - $36.63 $7.6 Million - $8.45 Million	230,627 Added 22.78%	1,242,882 $43.5 Million
Q4 2017 Jan 26, 2018	BUY	$32.09 - $34.78 $32.5 Million - $35.2 Million	1,012,255	1,012,255 $35.1 Million

Others Institutions Holding AZN

# of Institutions

1,356

Shares Held

475M

Call Options Held

5.14M

Put Options Held

3.06M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $202B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hardman Johnston Global Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hardman Johnston Global Advisors LLC with notifications on news.

Account

Hardman Johnston Global Advisors LLC Astrazeneca PLC Transaction History